About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in October
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in October
Mindrift is looking for specialists to design original computational biology problems, creating challenges that simulate real research workflows. Candidates should possess strong Python skills and a degree in Biology or related fields. The role requires contributions on a project
Mercor is seeking a STEM Computational Scientific Software & Evaluation Design expert to design computational problems for AI research. You will need graduate-level training in STEM, proficiency in scientific software libraries, and strong Python skills. The role
— About Eligo — Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is
About the job Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark, General Catalyst, Peter Thiel, Adam DAngelo, Larry Summers, and Jack Dorsey. Position: STEM
Professional | Permanent | Full-time | Hybrid If you’re passionate about changing lives for the better, this is the opportunity you’ve been waiting for. In Research & Development , we’re continuously exploring innovative new treatment options
About Us Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biology Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software.
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule‑invention platform, which uniquely combines cutting‑edge
Albert Invent is seeking an experienced individual for a critical role at the intersection of advanced AI and high-stakes biology. You will lead the development and integration of Owkin’s Data Transformation Agent, design data workflows, and guide
About Us Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biology Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software.
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in October
We are looking for a Senior Machine Learning Engineer to develop neural network architectures and algorithms to design new drug molecules and simulate their binding to human proteins, guided by our proprietary affinity calculations. You will
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast‑growing start‑up headquartered in Paris, incorporated in October
Biomemory, founded in 2021, boldly stands at the crossroads of Biotechnology and Computing, driven by a passion for sustainability. We are a well-funded start-up building IT rackable equipment for Data Centers , using synthetic DNA as
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines
AQEMIA is seeking a Senior Machine Learning Engineer in Paris to develop neural network architectures for designing new drug molecules and simulating their interactions with proteins. You will work within an 8-member team on innovative drug